Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) offers:

• Regional therapy for rare or complex cancers that have spread to the lining of the abdomen, such as appendiceal, colorectal, gastric and certain gynecologic cancers.
• An opportunity for improved survival and quality of life outcomes.
• Potentially curative option, even for patients with significant tumor burden